MESO

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Mesoblast Ltd

NASDAQ | MESO

14.92

USD

$0.00

(

0.00%

)

At Close (As of Nov 13, 2025)

$2.01B

Market Cap

-

P/E Ratio

-0.85

EPS

$22.00

52 Week High

$9.61

52 Week Low

HEALTHCARE

Sector

MESO Chart

Recent Chart
Price Action

MESO Technicals

Tags:

MESO Earnings

Yearly Income Statement (As of Jun 30, 2025)

Field Value (USD)
Gross Profit $12M
Total Revenue $17M
Cost Of Revenue $5.1M
Costof Goods And Services Sold $5.1M
Operating Income -$62M
Selling General And Administrative $23M
Research And Development $35M
Operating Expenses $75M
Investment Income Net -
Net Interest Income -$19M
Interest Income $3.6M
Interest Expense $23M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $6.4M
Income Before Tax -$102M
Income Tax Expense $330K
Interest And Debt Expense -
Net Income From Continuing Operations -$102M
Comprehensive Income Net Of Tax -
Ebit -$80M
Ebitda -$74M
Net Income -$102M

Revenue & Profitability

Earnings Performance

MESO Financials

yearly Balance Sheet (As of Jun 30, 2025)

Field Value (USD)
Total Assets $785M
Total Current Assets $204M
Cash And Cash Equivalents At Carrying Value $161M
Cash And Short Term Investments $161M
Inventory $22M
Current Net Receivables $15M
Total Non Current Assets $580M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $437M
Intangible Assets Excluding Goodwill $437M
Goodwill $134M
Investments -
Long Term Investments $1.4M
Short Term Investments -
Other Current Assets $6.1M
Other Non Current Assets -
Total Liabilities $187M
Total Current Liabilities $103M
Current Accounts Payable $19M
Deferred Revenue -
Current Debt -
Short Term Debt $57M
Total Non Current Liabilities $85M
Capital Lease Obligations $6.3M
Long Term Debt $68M
Current Long Term Debt $54M
Long Term Debt Noncurrent -
Short Long Term Debt Total $128M
Other Current Liabilities $27M
Other Non Current Liabilities $11M
Total Shareholder Equity $597M
Treasury Stock -
Retained Earnings -$1B
Common Stock $1.5B
Common Stock Shares Outstanding $121M

yearly Cash Flow (As of Jun 30, 2025)

Field Value (USD)
Operating Cashflow -$50M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $6.4M
Capital Expenditures $730K
Change In Receivables -
Change In Inventory $826K
Profit Loss -
Cashflow From Investment $120K
Cashflow From Financing $147M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout $0
Dividend Payout Common Stock $0
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$102M

yearly Income Statement (As of Jun 30, 2025)

Field Value (USD)
Gross Profit $12M
Total Revenue $17M
Cost Of Revenue $5.1M
Costof Goods And Services Sold $5.1M
Operating Income -$62M
Selling General And Administrative $23M
Research And Development $35M
Operating Expenses $75M
Investment Income Net -
Net Interest Income -$19M
Interest Income $3.6M
Interest Expense $23M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $6.4M
Income Before Tax -$102M
Income Tax Expense $330K
Interest And Debt Expense -
Net Income From Continuing Operations -$102M
Comprehensive Income Net Of Tax -
Ebit -$80M
Ebitda -$74M
Net Income -$102M

MESO News

MESO Profile

Mesoblast Ltd Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Mesoblast Ltd is a leading biopharmaceutical company headquartered in Melbourne, Australia, specializing in allogeneic cellular therapies aimed at addressing critical unmet medical needs. The firm is at the forefront of regenerative medicine, particularly with its innovative solutions for spine disorders, cardiovascular diseases, and inflammatory conditions, supported by robust clinical evidence. With a diverse and advanced product pipeline, Mesoblast is poised for significant growth, making it an appealing opportunity for institutional investors seeking exposure to the evolving landscape of therapeutic advancements.

NVVE
+204.60%
$0.47
LPTX
+368.57%
$2.05
TNMG
+37.18%
$0.41
CMND
+11.56%
$0.34
ONDS
+19.05%
$6.56
RUBI
+16.35%
$0.23
NVDA
-3.58%
$186.86
VHAI
-25.00%
$0.00
SOND
+8.82%
$0.18
PFE
-0.30%
$25.79
TSLA
-6.64%
$401.99
SOFI
-11.85%
$28.39
ASST
-10.85%
$1.15
PLUG
-8.79%
$2.49
BITF
-17.98%
$2.60
WTO
-33.55%
$0.02
YDKG
-18.03%
$0.02
INTC
-5.22%
$35.91
ACHR
-7.97%
$7.96
DRCT
+44.06%
$0.28
BYND
-9.41%
$1.01
DNN
-3.86%
$2.49
F
-1.26%
$13.28
SGBX
+32.21%
$3.16
ETHD
+14.22%
$5.14
MGRX
-32.38%
$1.19
AXDX
-61.36%
$0.03
RGTI
-10.95%
$25.20
PLTR
-6.53%
$172.14
AMD
-4.22%
$247.96
NIO
-3.25%
$6.24
SNAP
-5.61%
$8.58
RIVN
-6.44%
$16.39
CSCO
+4.62%
$77.38
NOK
-3.41%
$6.78
CIFR
-14.09%
$14.93
TLRY
-8.13%
$1.13
MARA
-11.31%
$12.78
GRAB
-4.31%
$5.54
CRCL
-4.58%
$82.34
CAN
-10.18%
$0.97
ADAP
-15.14%
$0.05
CHR
+3.90%
$0.04
T
+0.38%
$25.75
QBTS
-11.40%
$23.39
IREN
-12.65%
$48.65
AAPL
-0.19%
$272.95
BBD
-0.54%
$3.66
DIS
-7.74%
$107.61
WULF
-7.59%
$11.68
SOUN
-7.70%
$12.22
BTBT
-11.26%
$2.52
CRWV
-8.29%
$78.34
HPE
-2.34%
$22.93
NBIS
-6.07%
$88.63
RIG
-2.90%
$4.01
AMZN
-2.71%
$237.58
BMNR
-9.85%
$36.57
RMBL
+60.50%
$3.21
BTE
+3.63%
$3.14
UGRO
-16.39%
$0.25
LNW
-3.71%
$86.22
AAL
-2.89%
$13.07
ADD
-25.47%
$0.05
IONZ
+20.63%
$5.67
BAC
-2.29%
$52.87
SMCI
-7.43%
$35.09
IONQ
-10.47%
$45.40
GPUS
-10.20%
$0.30
SRM
+53.27%
$10.30
CLSK
-10.12%
$11.98
HIMS
-7.61%
$36.05
EPWK
-38.09%
$0.04
QS
-7.30%
$13.57
BURU
-8.60%
$0.25
MU
-3.24%
$236.95
JD
-1.72%
$30.71
APLD
-12.68%
$23.06
KVUE
+0.59%
$16.77
VZ
+0.75%
$41.11
WBD
-0.22%
$22.14
HOOD
-9.51%
$120.33
ORCL
-4.15%
$217.57
GOOGL
-2.83%
$278.57
BTG
-1.91%
$4.10
AMCR
+2.02%
$8.58
WLGS
-5.57%
$0.04
RIOT
-10.21%
$13.88
BE
-18.28%
$103.55
QUBT
-9.96%
$10.03
MTSR
-0.35%
$70.50
SMR
-10.82%
$23.15
PLTZ
+13.00%
$7.04
DKNG
-5.77%
$29.69
VSA
-20.34%
$0.23
JOBY
-9.26%
$14.79
RKLB
-9.44%
$45.25
NGD
-4.08%
$7.27
ABEV
-0.39%
$2.52
HBAN
-1.50%
$15.71
NVVE
+204.60%
$0.47
LPTX
+368.57%
$2.05
TNMG
+37.18%
$0.41
CMND
+11.56%
$0.34
ONDS
+19.05%
$6.56
RUBI
+16.35%
$0.23
NVDA
-3.58%
$186.86
VHAI
-25.00%
$0.00
SOND
+8.82%
$0.18
PFE
-0.30%
$25.79
TSLA
-6.64%
$401.99
SOFI
-11.85%
$28.39
ASST
-10.85%
$1.15
PLUG
-8.79%
$2.49
BITF
-17.98%
$2.60
WTO
-33.55%
$0.02
YDKG
-18.03%
$0.02
INTC
-5.22%
$35.91
ACHR
-7.97%
$7.96
DRCT
+44.06%
$0.28
BYND
-9.41%
$1.01
DNN
-3.86%
$2.49
F
-1.26%
$13.28
SGBX
+32.21%
$3.16
ETHD
+14.22%
$5.14
MGRX
-32.38%
$1.19
AXDX
-61.36%
$0.03
RGTI
-10.95%
$25.20
PLTR
-6.53%
$172.14
AMD
-4.22%
$247.96
NIO
-3.25%
$6.24
SNAP
-5.61%
$8.58
RIVN
-6.44%
$16.39
CSCO
+4.62%
$77.38
NOK
-3.41%
$6.78
CIFR
-14.09%
$14.93
TLRY
-8.13%
$1.13
MARA
-11.31%
$12.78
GRAB
-4.31%
$5.54
CRCL
-4.58%
$82.34
CAN
-10.18%
$0.97
ADAP
-15.14%
$0.05
CHR
+3.90%
$0.04
T
+0.38%
$25.75
QBTS
-11.40%
$23.39
IREN
-12.65%
$48.65
AAPL
-0.19%
$272.95
BBD
-0.54%
$3.66
DIS
-7.74%
$107.61
WULF
-7.59%
$11.68
SOUN
-7.70%
$12.22
BTBT
-11.26%
$2.52
CRWV
-8.29%
$78.34
HPE
-2.34%
$22.93
NBIS
-6.07%
$88.63
RIG
-2.90%
$4.01
AMZN
-2.71%
$237.58
BMNR
-9.85%
$36.57
RMBL
+60.50%
$3.21
BTE
+3.63%
$3.14
UGRO
-16.39%
$0.25
LNW
-3.71%
$86.22
AAL
-2.89%
$13.07
ADD
-25.47%
$0.05
IONZ
+20.63%
$5.67
BAC
-2.29%
$52.87
SMCI
-7.43%
$35.09
IONQ
-10.47%
$45.40
GPUS
-10.20%
$0.30
SRM
+53.27%
$10.30
CLSK
-10.12%
$11.98
HIMS
-7.61%
$36.05
EPWK
-38.09%
$0.04
QS
-7.30%
$13.57
BURU
-8.60%
$0.25
MU
-3.24%
$236.95
JD
-1.72%
$30.71
APLD
-12.68%
$23.06
KVUE
+0.59%
$16.77
VZ
+0.75%
$41.11
WBD
-0.22%
$22.14
HOOD
-9.51%
$120.33
ORCL
-4.15%
$217.57
GOOGL
-2.83%
$278.57
BTG
-1.91%
$4.10
AMCR
+2.02%
$8.58
WLGS
-5.57%
$0.04
RIOT
-10.21%
$13.88
BE
-18.28%
$103.55
QUBT
-9.96%
$10.03
MTSR
-0.35%
$70.50
SMR
-10.82%
$23.15
PLTZ
+13.00%
$7.04
DKNG
-5.77%
$29.69
VSA
-20.34%
$0.23
JOBY
-9.26%
$14.79
RKLB
-9.44%
$45.25
NGD
-4.08%
$7.27
ABEV
-0.39%
$2.52
HBAN
-1.50%
$15.71
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.